Active metabolites formed during hepatic first-pass: simulations featuring their contribution to the overall effect in altered liver clearance and drug-drug interactions
- In: Bioavailability/Bioequivalence - Posters
- At: Istanbul (Turkey) (2009)
- Type: Poster
- Poster code: BB-P-007
- By: ABDELAZIZ, Ahmed (German University in Cairo, Cairo, Egypt)
- Co-author(s): Alaraby, Mohammad (German University in Cairo, CAIRO, Egypt)
Mahran, Laila (German University in Cairo, CAIRO, Egypt)
Spahn-Langguth, Hilde (University of Graz, GRAZ, Austria) - Abstract:
Phase-I- and - occasionally - also phase-II metabolites may contribute to the overall effect of a drug. This is not always apparent or revealed, since total concentrations of metabolites may be low in relation to parent drug concentrations. In the case of carvedilol, using a comparison of HPLC and beta 1-specific radioligand-receptor-binding assay ..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023